Curis Lifesciences Limited
ListedSMEPharmaceuticals · NSE
Curis Lifesciences Limited, founded in 2010, is a pharmaceutical company engaged in developing, manufacturing, and distributing a wide range of medicines. It produces pharmaceutical products for both domestic and global markets through loan license, contract manufacturing, and its own brand marketing. The company serves over 100 corporate clients under contract manufacturing and two clients for its own brands in Yemen and Kenya. Its product range includes tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates a modern manufacturing facility in Sanand, Gujarat, maintaining strict quality standards, and as of July 31, 2025, it employs 95 permanent staff.
Price Band
₹120 – ₹128
Issue Size
₹27.52 Cr
Lot Size
1000 shares
GMP
₹7
+5.5%
Est. Listing
₹135
at current GMP
Subscribed
74.47x
overall
Open
7 Nov 2025
Close
11 Nov 2025
Allotment
12 Nov 2025
Refund
13 Nov 2025
Demat Credit
14 Nov 2025
Listing
14 Nov 2025
Last updated 12 days ago
Overall Subscription
74.47x
Total Demand
QIB Multiplier
96.17x
Institutions & Funds
NII / HNI
115.81x
High Net-Worth
Retail (RII)
44.28x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 409,000 | 39,335,000 | 96.17x |
| NIB | 308,000 | 35,671,000 | 115.81x |
| HNIs(10L +) | 206,000 | 29,512,000 | 143.26x |
| HNIs (2-10L) | 102,000 | 6,159,000 | 60.38x |
| RETAIL | 716,000 | 31,706,000 | 44.28x |
| Total | 1,741,000 | 142,383,000 | 74.47x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 44 | 0.00x |
| NIB | — | 5,576 | 0.00x |
| RETAIL | 358 | 15,853 | 44.28x |
| HNIs(10L +) | 69 | 3,605 | 52.25x |
| HNIs (2-10L) | 34 | 1,971 | 57.97x |
| Total Applications | 461 | 27,049 | 58.67x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Curis Lifesciences Limited Public Issue & Market Profile
Curis Lifesciences Limited is bringing an initial public offering (IPO) in the Pharmaceuticals sector with an aggregate issue size of ₹27.52 Crores. The shares are offered at a price band of ₹120 to ₹128 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,28,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-11-14, while un-allotted funds or UPI block mandates will be released on 2025-11-13.
Frequently Asked Questions
What is Curis Lifesciences Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Curis Lifesciences Limited IPO is ₹7 per equity share. Based on the upper price band of ₹120 to ₹128 per equity share, the estimated listing price is ₹135 (+5.5% expected listing gain).
What is the expected profit per lot for Curis Lifesciences Limited IPO?
With a lot size of 1000 shares and current GMP of ₹7, the expected profit per application lot is approx ₹7,000 (+5.5% gain). Minimum application cost is approx ₹1,28,000.
What is the issue size and price band for Curis Lifesciences Limited IPO?
The Curis Lifesciences Limited IPO aggregate issue size is ₹27.52 Crores with an equity price band set at ₹120 to ₹128 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,28,000.
How can I check Curis Lifesciences Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 74.47x (Retail: 44.28x, QIB: 96.17x, NII: 115.81x). You can track live multiples directly on our dedicated subscription page.
Where and when will Curis Lifesciences Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2025-11-12. Investors can verify status using PAN card or application number.
When is the listing date for Curis Lifesciences Limited IPO?
Curis Lifesciences Limited shares are scheduled to list on NSE on 2025-11-14.